Swiss Market Ends Slightly Up
After staying in positive territory till a little past noon, the Switzerland stock market turned weak and finally ended Friday's session with a small gain.
Rising hopes about Covid-19 vaccines sometime soon helped lift sentiment, while continued surge in coronavirus cases and uncertainty about a fiscal stimulus in the U.S. limited market's uptick.
The benchmark SMI, which touched a high of 10,528.33 and a low of 10,450.61, ended up 4.88 points or 0.05% at 10,495.65.
SGS gained a little over 1%. Sika and Richemont both ended nearly 1%. Novartis, LafargeHolcim, Zurich Insurance Group, Swiss Life Holding, Credit Suisse and Geberit gained 0.5 to 0.7%.
Shares of Swiss Re gained 0.75% after the insurance major confirmed its over-the-cycle financial targets. The company reiterated its capital management priorities, focusing on capitalisation and a stable or increasing dividend.
ABB and Lonza Group lost 1.2% and 1.05%, respectively. Partners Group declined 0.7%, while Nestle and Roche Holding shed 0.4% and 0.3%, respectively.
Among the stocks in the Mid Price index, Tecan Group and Kuehne & Nagel both ended higher by about 2.35%. Logitech gained 2.1%, while Barry Callebaut, Vifor Pharma, OC Oerlikon Corp, Baloise Holding, Schindler and Dufry gained 1 to 1.7%.
Reprinted from RTTNews，the copyright all reserved by the original author.
Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.
FOLLOWME Trading Community Website: https://www.followme.com
Hot
No comment on record. Start new comment.